the microvascular architecture of LTS when clinicopathological evidence of cutaneous GVHD is absent. Microvascular remodeling as observed during chronic GVHD recovers completely after resolution of chronic cutaneous GVHD.
Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (HSCT). Its acute or chronic form is the main cause of nonrelapse morbidity and mortality both as a direct complication (e.g. bronchiolitis obliterans) or via associated immunodeficiency and susceptibility to severe infections [1] [2] [3] .
Contrary to some expectations, the incidence of GVHD did not significantly decrease over the last 20 years, and still develops in about half of all patients undergoing allogeneic HSCT [4] . While novel transplantation techniques such as reduced-intensity conditioning regimens are associated with less severe acute GVHD rel-ative to myeloablative regimens, the incidence of acute GVHD has remained unchanged [4, 5] . By comparison, extended eligibility criteria for patients undergoing transplantation (e.g. increased upper age limit), increased human leukocyte antigen disparity, prolonged initial survival due to reduction of early mortality as a consequence of better prophylaxis and treatment strategies of immediate complications of transplantation (e.g. acute GVHD and infections), and increased use of peripheral blood stem cells have increased the risk for chronic GVHD [6] .
Cutaneous GVHD is divided into an acute and chronic form and has recently been reviewed by our group [7] . Acute GVHD is pathophysiologically well understood and initiation and maintenance involves various host and recipient immunocompetent cells as well as noncellular molecules [8, 9] . In contrast, the pathogenesis of chronic GVHD is more complex and thought to be primarily an immune-mediated process that mostly involves alloreactive CD4+ and CD8+ T cells as main effectors [10] . As a hallmark feature, chronic GVHD may present with clinical and laboratory findings that resemble various autoimmune disorders, e.g. bronchiolitis obliterans, Sjögren's syndrome, immune cytopenias, and cutaneous sclerosis, suggesting that dysfunctional humoral immunity might be involved in the pathogenesis as well [11] [12] [13] .
It has previously been shown that patients with active chronic GVHD have significantly reduced microvessels in skin compared to healthy controls [14] . It has been hypothesized that antiendothelial immune attack and subsequent vessel loss in these patients is the result of alloreactive antiendothelial cytotoxic T cells. However, in this former study we had no access to skin biopsies from longterm survivors (LTS) free of cutaneous GVHD. Therefore, we could not rule out that the process of allogeneic HSCT itself would affect microvascular remodeling in the skin.
In this present study, we investigated skin biopsies of a homogeneous population of 32 recipients more than 10 years after allogeneic HSCT who lacked any clinical signs of cutaneous GVHD at the time of biopsy. The main aim of our investigations was to examine the cutaneous microvasculature in LTS of allogeneic HSCT, to determine whether in these individuals vascular remodeling (vessel size distribution pattern) or restitutio ad integrum (complete reconstitution of vessel quantity and normal vessel size distribution pattern) of the cutaneous microvascular network occurs, and to eventually establish microvascular criteria for subclinical GVHD.
Patients and Methods

Patients
We investigated skin biopsies of 32 allogeneic stem cell transplant recipients more than 10 years after myeloablative bone marrow transplantation. Table 1 summarizes the key data of the study population (LTS). Roughly 2/3 of our LTS previously experienced acute GVHD demonstrating classical erythematous rash that resolved within days to a few weeks after standard treatment (systemic glucocorticoids). LTS who previously experienced limited chronic GVHD had localized sclerodermatous skin disease, while patients with extensive chronic GVHD had a generalized cutaneous involvement including fibrosing forms. Our study was a cooperative project related to the single-center prospective study in Basel entitled 'Altered immunity in longterm survivors after allogeneic hematopoietic stem cell transplantation as compared with their respective donors'. All 44 recipients and their respective donors gave written informed consent to the protocol that was approved by the local institutional ethics review board. For the cooperative project, the ethics review board only allowed to take skin biopsies from recipients but not from their respective donors. Of the 44 recipients, 4 refused skin biopsy and the remaining 40 patients gave written informed consent. Of those, 32 samples were considered representative and could be further investigated [32 for confocal microscopy and 28 for immunohistochemistry (IHC)]. Eight samples (for confocal microscopy) and 12 samples (for IHC) could not be processed for various technical reasons and were independently qualified as insufficient by two of us (P.H., E.K.). Formalinfixed, paraffin-embedded 6-mm punch biopsies were taken from normal-appearing and sun-protected skin, such as on the back, thigh, abdomen, upper arm or gluteal. At the time of biopsy, all recipients of our cohort did not show any clinical signs of cutaneous GVHD. Table 1 summarizes all important data of the other investigated groups apart from LTS, i.e. patients with chronic sclerotic GVHD and those who never had allogeneic HSCT (healthy controls, patients with lichen sclerosus, and patients with morphea). Except for healthy controls, 4-mm punch biopsies of the lateral borders of lesional skin were taken exclusively for diagnostic purposes after patient's consent and before the start of this prospective study. All patients with chronic cutaneous GVHD of sclerotic type presented homogeneously with hallmark clinical and histopathological features of chronic sclerotic GVHD of skin. Patients with morphea and lichen sclerosus presented the classical clinical and histopathological characteristics of the respective disease. Normal-appearing skin of healthy controls was taken after patient's consent from the edges of spindle excisions for cosmetically distracting and required removals of benign fibromas and papillomatous melanocytic nevi.
Slide Preparation
We embedded formalin-fixed skin biopsy samples in paraffin and cut 5-mm-thick sections. Paraffin was removed by xylol and treatment with 100, 96, and 70% ethanol. After rinsing the slides in phosphate-buffered saline (PBS; pH 7.4), we demasked the antigens in 10 mmol/l citrate buffer (pH 6) in a steam presser chamber for 2 min. The slides were washed again with PBS.
Immunohistochemistry
Before IHC, slides were preincubated with 3% hydrogen peroxide in 50% methanol. Vascular endothelial cells were detected with antibody against von Willebrand factor (vWF). We incubated slides with rabbit anti-vWF (1: 600, DAKO) and a peroxidase-conjugated goat anti-rabbit antibody (EnVision System HRP rabbit, DAKO). DAB EnVision kit was used for detection (DAKO). Slides were analyzed with a light microscope (Leica DM 2500, Leica Microsystems, Wetzlar, Germany) and photographed with a digital camera.
Immunof luorescence
Nonspecific binding sites were blocked with 3% fat-free dry milk in PBS for 30 min at room temperature. Vascular endothelial cells were detected with anti-vWF antibody (1: 200, DAKO) for 1 h at room temperature. Slides were rinsed with PBS and incubated with cyanine 5 (Cy5)-conjugated donkey anti-rabbit antibody (1: 800, Jackson ImmunoResearch, West Grove, Pa., USA) for 30 min at room temperature. The slides were then rinsed again with PBS and mounted under glass with hydrophilic embedding medium (Faramount, DAKO). Immunofluorescence (IF) was detected with a confocal microscope (Zeiss, Jena, Germany).
Quantitative Morphometric Analysis of Microvessel Density
For each patient, one microscopy slide containing a representative paraffin section from the skin biopsy was analyzed. For IHC slides, one image per slide was taken. In the superficial dermis (a subepidermal region 150-200 mm deep), we determined the area to be analyzed and then counted the number of vessels and measured the diameter of vascular profiles lined by endothe- Figures in parentheses indicate ranges or percentages. 1 Acute GVHD grade 0: n = 11 (34.4%); grade I: n = 4 (12.5%); grade II: n = 13 (40.6%); grade III: n = 4 (12.5%); grade IV: n = 0 (0%). . Total profile counts/mm 2 as well as profile count per category were determined. Results were calculated as median profile number/mm 2 (total profile density) and median profile number per category divided by median total count (percent of total count). For IF-stained slides, four representative images were taken in the superficial dermis and the median of four results was calculated as representative value per slide. Fluorescence images were analyzed with Adobe Photoshop software. Total pixel number of the area to be analyzed was determined. Within this area, the number of pixels matching the wavelength of Cy5 ( fig. 1 , blue in the online version) was determined. Results were normalized according to the total pixel number of the corresponding area, and were calculated as median pixel number per total area pixel number for each patient group.
Skin Vessels in Bone Marrow Transplantation
Antibodies
Rabbit anti-vWF (DAKO A0082) was used for vWF detection in both IHC and IF. Donkey anti-rabbit Cy5 (Jackson 711-175-152) was used as a secondary antibody in IF. Rabbit serum was used for negative controls in both applications.
Data Analysis and Statistics
Total profile number/mm 2 as well as relative vWF pixel counts are represented as medians. Mann-Whitney U test was performed for statistical significance to determine differences between patient groups and controls. Differences with p ! 0.05 were considered significant. Comparison between the two endothelial cell measurement methods (profile number/mm 2 and Cy5 matching pixels per total pixels) was analyzed with the Spearman correlation coefficient. Profile size distribution analysis (group comparisons) was tested for statistical significance with a 2 test. Differences with p ! 0.05 were considered significant.
Results
Chronic Sclerotic GVHD and Lichen Sclerosus Are Vanishing Vessel Diseases of the Upper Dermis
In this study, we investigated the status of microvasculature in skin of a large homogeneous population of allogeneic stem cell recipients with a median follow-up of 17 years after transplantation. We morphometrically assessed number and size categories of blood vessels defined by immunohistochemical positivity for vWF within the upper dermal layers (150-200 mm downward from basal membrane) anatomically corresponding to the compartment of the superficial vascular plexus in skin. and nontransplanted healthy controls (n = 6). The anatomical findings of the superficial ( fig. 1 , upper row) and deep ( fig. 1 , lower row) dermis are shown with a highand low-power view, respectively. LTS and healthy controls hereby present similar morphological findings with respect to vessel count, vessel size and collageneous matrix. In contrast, chronic sclerotic GVHD reveals homogenization, enlargement and compactation of collagen fibers of the upper and lower dermis and rarification of vessels particularly in the upper dermal parts. Morphea, an idiopathic sclerotic skin disorder with prominent compactation and homogenization of collagen fibers primarily of deep dermal parts, discloses upper dermal matrix and vessel characteristics similar to those of LTS and healthy controls. Lichen sclerosus, a fibrosing skin disease with compactation and homogenization of collagen of the uppermost parts of the dermis, demonstrates prominent vessel rarification in the papillary dermis within a sclerotic matrix.
Higher Interindividual Variability of Microvascular Density in LTS Compared to Healthy Controls
Two independent morphometric methods were used to assess microvascular density in the skin (for details, fig. 2 and Methods). Figure 3 indicates the microvascular density determined as counted absolute number of vessel profiles/mm 2 ( fig. 3 a) and as vWF-positive pixel number per total pixel number of the area analyzed ( fig. 3 b) .
Equal vascular densities are assessed in LTS and healthy controls by both independent quantification methods (vessels/mm 2 : 48.3 compared to 47.9, p = 0.947; pixels: 1,190 compared to 1,138, p = 0.719, Mann-Whitney U test). This finding is independent of whether LTS previously experienced any GVHD or were currently classified as having chronic GVHD without skin involvement [vessels/mm 2 : 51.9 (no GVHD) compared to 48.3 (any previous GVHD), p = 0.872; pixels: 902 (no GVHD) compared to 1,248 (any GVHD), p = 0.478, Mann-Whitney U test].
Compared to healthy controls (47.9 vessels/mm 2 and 1,138 pixels), an anticipated significant decrease in absolute vessel count was found in chronic sclerotic GVHD (19.3 vessels/mm 2 , p = 0.038; 678 pixels, p = 0.018) and lichen sclerosus (20.0 vessels/mm 2 , p = 0.017; 344 pixels, p = 0.011). Also when compared to LTS, the two sclerotic disorders show a significant decrease in vessel count (p = 0.008) and vWF pixels per total area (p = 0.044) for chronic sclerotic GVHD, as well as for lichen sclerosus (p = 0.003, vessels/mm 2 ; p = 0.006, vWF pixels). In contrast, morphea does not demonstrate significant changes of vessel density (51.6 vessels/mm 2 , p = 0.945; 854 vWF pixels, p = 0.361, Mann-Whitney U test). This is in accordance with the anatomical matrix changes particularly of the lower dermis sparing the upper parts ( fig. 1 ) .
However, LTS show a broad range of microvascular density as compared to healthy controls by both independent methods. This interindividual variability of microvascular densities within the LTS group was further explored by analyzing the four quartile groups ( table 2 ; fig. 3 a) . The lowest subgroup of patients (1st quartile of data values) in fact shows a significant reduction in vessel density compared to healthy controls (p = 0.003 for vessels/mm 2 , p = 0.013 for pixels, Mann-Whitney U test), while the highest subgroup (4th quartile) demonstrates a significant increase in vessel density (p = 0.032 for vessels/mm 2 , p = 0.042 for pixels, Mann-Whitney U test; data not shown). The 2nd and the 3rd quartiles are not different from the healthy controls. Importantly, when the 1st and the 4th quartiles were systematically investigated for parameters such as recipients' gender, age at transplantation, time interval after allogeneic HSCT, conditioning regimens with or without total body irradiation or previous or current status of GVHD ( table 2 ) , we did not find any association between one of these characteristics and vessel quantity.
Finally, we compared the two quantification methods (vessel counts versus pixel measurement) by correlating the two data sets. As we generated in parallel one total vessel number/mm 2 (IHC) and one pixel value per area for each patient sample, we compared each pair of corresponding values using the Spearman correlation analysis over all patient groups including healthy controls (a total of 50 pairs). Statistical analysis revealed a Spearman correlation coefficient of 0.406 and a p value of 0.003 (data not shown), indicating a clear correlation between the two measurement methods. , chronic sclerotic GVHD (11.3 vessels/mm 2 , p = 0.008) as well as lichen sclerosus (12.5 vessels/mm 2 , p = 0.003) showed a significant decrease in the absolute number of vascular profiles in the smallest vessel category. Furthermore, chronic sclerotic GVHD and lichen sclerosus demonstrate a relative but not significant increase in large microvessels ( 1 20 mm) .
No Microvascular Remodeling in LTS and in Chronic Sclerotic GVHD
By investigating the relative size distribution of microvessels per total vessel profile numbers (criteria for vascular remodeling), figure 4 b demonstrates that the very small vessels either with no or very thin lumens (0-10 mm) are the most prevalent vascular structures in all groups relative to the total profile numbers/mm 2 and compared to healthy controls. Importantly, and here shown for all vessel size categories, LTS and healthy controls have a nearly identical vessel size distribution pattern.
Taken together, the terminal vascular bed in the uppermost skin of LTS is therefore almost identical to that of healthy controls in terms of the relative distribution of vessel size categories. Moreover, the relative size distribution of vessel profiles within one group (no lumen, 0-10, 10-20, 1 20 mm) did not show any significant changes ( 2 test, p values are indicated in fig. 4 ) compared to healthy controls in any of the four investigated groups. Particularly with respect to diseases with quantitative loss of microvessels such as chronic sclerotic GVHD and lichen sclerosus, there is no evidence that the microvascular loss would occur preferentially in one vessel size category. The LTS group of GVHD patients has been divided into 4 subgroups according to the patient's vessel profile density; each group represents a quartile range. No correlation of the vessel density quartile groups with any of the observed parameters can be seen.
Discussion
In this observational study, we investigated the current status of the cutaneous microvasculature in a large homogeneous cohort of hematopoietic stem cell recipients more than 10 years after transplantation. Our primary aim was to capture all information about absolute number of vessels in skin (criteria for reconstitution) and relative distribution of vessel size categories (criteria for remodeling) to objectify any subclinical long-term sequelae related to that therapy. Vascular structures were assessed according to immunohistochemical and IF reactivity for vWF (for details see fig. 2 ), a glycoprotein synthesized by vascular endothelial cells and stored in the Weibel-Palade bodies [15] . All recipients (LTS) revealed a high degree of homogeneity with respect to their condi- tioning and transplant procedures and did not show any clinical and histological signs of cutaneous GVHD at the time of follow-up and skin biopsy ( table 1 ). Our study was part of a cooperative project related to the single-center prospective study in Basel entitled ' Altered immunity in long-term survivors after allogeneic hematopoietic stem cell transplantation as compared with their respective donors'.
Our main findings can be summarized as follows. First, LTS without clinical signs of chronic cutaneous GVHD and healthy controls demonstrate comparable morphological features with respect to dermal matrix and vascular structures ( fig. 1 ) as compared to patients with chronic sclerotic GVHD and lichen sclerosus [14, 16] . Second, quantitative assessment of microvascular density by two independent methods ( fig. 3 a, b) shows identical absolute numbers of vessel profiles in LTS and healthy controls. Both measurement methods thereby correlate with a Spearman correlation coefficient of 0.406 (figure not shown). With respect to the increased interindividual variability in vessel density of LTS as compared to healthy controls, and based on the subsequent quartile group analysis of LTS ( table 2 ), we were not able to identify any discriminating parameters within these subgroups such as sex and age at transplantation, conditioning regimens, years after transplantation, and, importantly, current or previous status of GVHD. This is particularly remarkable, as a significant blood vessel loss has been previously demonstrated in skin biopsies of allogeneic stem cell recipients with clinical features of chronic GVHD [14] and here confirmed by us ( fig. 3 ) . Third, LTS and healthy controls do essentially demonstrate an equal absolute vessel profile number per size category ( fig. 4 a) and a comparable relative vessel profile size distribution pattern ( fig. 4 b) . These are crucial arguments against persistent vascular sequelae of skin of LTS more than 10 years after transplantation. Furthermore, we did not find any correlation of the serum vWF of these LTS (data not shown) to any of the clinical parameters listed in table 2 and their respective vascular density. It finally could be hypothesized that beyond previous occurrence or absence of GVHD, peritransplant procedures and diseases such as viral infections do not have a sustained impact on the terminal vascular bed in skin of LTS.
Human microvasculature in normal skin and pathological conditions have previously been visualized in detail using laser Doppler flowmetry highlighting the microanatomical organization of the upper and lower horizontal vascular plexus and the connecting vessels [17] [18] [19] .
Past investigations elucidated that various immune-mediated fibrosing skin diseases result in similar modifications of vascular structures, cellular and molecular events as well as matrix changes. Vertically oriented capillary loops originating from and terminating in the upper vascular plexus were found to be transpositioned in lichen sclerosus from vertical to horizontal orientation toward the basal membrane zone [16] . Induction of sclerosis in fibrosing skin diseases such as chronic sclerotic GVHD, morphea and lichen sclerosus has been demonstrated to be critically mediated by TGF-␤ -induced activation of fibroblasts with subsequent collagen production and the simultaneous stimulation of tissue inactivators for metalloproteinases and increases in platelet-derived growth factor-␣ receptor expression in fibroblasts and endothelial endothelin-1 synthesis [20, 21] .
Our findings in LTS address further vascular aspects to the enhanced risk of premature cardiovascular disease recently demonstrated in 265 recipients of allogeneic hematopoietic stem cell transplants with a median followup of 9 years [22] . Though these late vascular events have not been observed in a patient cohort comparable to our homogeneous group of LTS, a relevant number of registered arterial episodes in these patients such as stroke, coronary heart disease, or peripheral arterial disease have been observed many years after transplantation with well-defined risk factors for endothelial damage such total body irradiation [23] or GVHD [14] . Essentially, the terminal vascular bed in skin comprises mainly capillaries, postcapillary venules, and few arterioles, but lack larger arteries. Hypothetically, micro-and macrovascular structures biologically behave differently after acute and/or chronic damage and might have unequal capabilities to recover.
In summary, in this study we demonstrated the complete remodeling and partial reconstitution of the terminal vascular bed in skin of a homogeneous cohort of LTS more than 10 years after allogeneic HSCT and irrespective of the former occurrence of GVHD involving skin. It can be hypothesized that peritransplant procedures such as total body irradiation, chemotherapy, GVHD, drug reactions or infections do not have a sustained impact on the ability of the skin to recover a complete microvasculare network many years after allogeneic HSCT.
